Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism-Reference-Cited by-同舟云学术

Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism

Published:2004-02-03 Issue:3 Volume:55 Page:426-430
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Varrone Andrea,Salvatore Elena,De Michele Giuseppe,Barone Paolo,Sansone Valeria,Pellecchia Maria Teresa,Castaldo Imma,Coppola Giovanni,Brunetti Arturo,Salvatore Marco,Pappatà Sabina,Filla Alessandro

Funder

Amersham Health

Italian Ministry of University and FIRB

FIRB (Fondo per gli Investimenti nella Ricerca di Base)

Ministry of Health

Biological Markers in Par-kinson's Disease 2000, Italy

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference17 articles.

1. Autosomal dominant spinocerebellar ataxias ad infinitum?;Subramony;Neurology,2001

2. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families;Cancel;Hum Mol Genet,1997

3. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia;Geschwind;Am J Hum Genet,1997

4. Spinocerebellar ataxia type 2 in China: molecular analysis and genotype-phenotype correlation in nine families;Zhou;Neurology,1998

5. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba. Clinical, neuropathological, and biochemical findings;Orozco;J Neurol Sci,1989

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapy Development for Spinocerebellar Ataxia: Rating Scales and Biomarkers;Contemporary Clinical Neuroscience;2023

2. Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2;International Journal of Molecular Sciences;2022-10-07

3. Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy;Cell Death & Disease;2021-11-29

4. Spinocerebellar ataxia clinical trials: opportunities and challenges;Annals of Clinical and Translational Neurology;2021-05-21

5. Rating scales and biomarkers for CAG-repeat spinocerebellar ataxias: Implications for therapy development;Journal of the Neurological Sciences;2021-05